Kanchan Dongre

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Combination Therapy

Affordable Care Act

Peripheral Blood

Top Venues

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Tarun Mehra, Kanchan Dongre, Maria Boesing, Patricia Frei, Claudia Suenderhauf, Alfred Zippelius, Joerg D Leuppi, Andreas Wicki, Anne B Leuppi-Taegtmeyer
Pre-treatment comorbidities, C-reactive protein and eosinophil count, and immune-related adverse events as predictors of survival with checkpoint inhibition for multiple tumour entities. Cancer medicine (2023)
Tarun Mehra, Kanchan Dongre, Maria Boesing, Patricia Frei, Claudia Suenderhauf, Alfred Zippelius, Joerg D Leuppi, Andreas Wicki, Anne B Leuppi-Taegtmeyer
Pre-treatment comorbidities, C-reactive protein and eosinophil count, and immune-related adverse events as predictors of survival with checkpoint inhibition for multiple tumour entities. Cancer medicine (2023)
Tarun Mehra, Kanchan Dongre, Maria Boesing, Patricia Frei, Claudia Suenderhauf, Alfred Zippelius, Joerg D Leuppi, Andreas Wicki, Anne B Leuppi-Taegtmeyer
Pre-treatment comorbidities, C-reactive protein and eosinophil count, and immune-related adverse events as predictors of survival with checkpoint inhibition for multiple tumour entities. Cancer medicine (2023)
Tarun Mehra, Kanchan Dongre, Maria Boesing, Patricia Frei, Claudia Suenderhauf, Alfred Zippelius, Joerg D Leuppi, Andreas Wicki, Anne B Leuppi-Taegtmeyer
Pre-treatment comorbidities, C-reactive protein and eosinophil count, and immune-related adverse events as predictors of survival with checkpoint inhibition for multiple tumour entities. Cancer medicine (2023)
Kanchan Dongre, Anja Jungo, Selina Späni, Yvonne Zysset, Anne B Leuppi-Taegtmeyer
Disease-Drug Interactions Requiring Special Attention. Praxis 111 (12) (2022)